High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer

Brachytherapy ◽  
2017 ◽  
Vol 16 (2) ◽  
pp. 299-305 ◽  
Author(s):  
Shyamal Patel ◽  
D. Jeffrey Demanes ◽  
Omar Ragab ◽  
Mingle Zhang ◽  
Darlene Veruttipong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
Androgen Deprivation Therapy ◽  
High Dose Rate ◽  
Androgen Deprivation ◽  
High Dose ◽  
Intermediate Risk ◽  
High Dose Rate Brachytherapy ◽  
Risk Prostate Cancer

scholarly journals 171 High-Dose-Rate Brachytherapy as Monotherapy for the Treatment of Intermediate Risk Prostate Cancer: Toxicity Results

2019 ◽  
Vol 139 ◽  
pp. S73
Author(s):  
Yousef Katib ◽  
Cyrus Sani ◽  
Richard Sioufi ◽  
Sergio Faria ◽  
Armen Aprikian ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Dose Rate ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
High Dose Rate Brachytherapy ◽  
Risk Prostate Cancer

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer

2015 ◽  
Vol 117 (2) ◽  
pp. 252-257 ◽  
Author(s):  
Shafak Aluwini ◽  
Wendy M.H. Busser ◽  
Wendimagegn Ghidey Alemayehu ◽  
Joost L. Boormans ◽  
Wim J. Kirkels ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Dose Rate ◽  
High Dose Rate ◽  
High Dose ◽  
Intermediate Risk ◽  
High Dose Rate Brachytherapy ◽  
Risk Prostate Cancer
Sign in / Sign up

Export Citation Format

Share Document